Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Adolescent Acute Lymphoblastic Leukemia
NCT05326984Unknown
- Sponsor
- Hospital General de México "Dr. Eduardo Liceaga"
- Start
- Feb 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of liquid metformin (Aspargo Labs) in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Hospital General de México "Dr. Eduardo Liceaga". Primary endpoints: ABCB1 gene expression at day 33 and AMPK gene expression at day 33. Status: unknown.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT05326984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05326984.